SCHEMBL20810312

SCHEMBL20810312

CCCCCCCCc1cccc(C(=O)NCC(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.56
PPARG P37231 2/20 0.56
SPHK2 Q9NRA0 1/20 0.56
SPHK1 Q9NYA1 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.52
NAAA Q02083 1/20 0.51
SMPD1 P17405 1/20 0.49
PDE5A O76074 1/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAP1LC3B Q9GZQ8 1/20 0.47
MAP1LC3A Q9H492 1/20 0.47
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
LPL P06858 1/20 0.47
LIPG Q9Y5X9 1/20 0.47
S1PR4 O95977 1/20 0.46
S1PR1 P21453 1/20 0.46
S1PR5 Q9H228 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20810289 0.87 SPHK2 (0.59) PPARAPPARGSPHK2SPHK1SMN1; SMN2
SCHEMBL20810562 0.87 SPHK2 (0.54) PPARAPPARGSPHK2SPHK1SMN1; SMN2
SCHEMBL20810326 0.84 ALOX5 (0.46) PPARGSPHK2SPHK1SMN1; SMN2PDE5A
SCHEMBL18020999 0.84 ALOX5 (0.46) PPARGSPHK2SPHK1SMN1; SMN2PDE5A
SCHEMBL20810487 0.84 ALOX5 (0.46) PPARGSPHK2SPHK1SMN1; SMN2PDE5A
SCHEMBL8884118 0.83 RARB (0.59) ALDH1A1
SCHEMBL9215324 0.83 RARB (0.59) ALDH1A1
SCHEMBL15174533 0.83 SPHK2 (0.64) PPARAPPARGSPHK2SPHK1SMN1; SMN2
SCHEMBL15173985 0.83 SPHK2 (0.64) PPARAPPARGSPHK2SPHK1SMN1; SMN2
SCHEMBL29013699 0.83 SMPD1 (0.67) PPARAPPARGSPHK2SPHK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3077369-B1 BENZAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF MUSCULAR DISORDERS AND PAIN AND FOR CONTROLLING SPASTICITY AND TREMORS UCL BUSINESS PLC (GB) 2019-03-13 EP disclosed